Zai Lab (ZLAB) EBITDA Margin (2020 - 2026)
Zai Lab (ZLAB) reported EBITDA Margin of 1711.1% for Q1 2026, down 165780.0% on a YoY basis from N/an in Q1 2025, and down 8225.41% sequentially from 21.06% in Q4 2025.
Zai Lab (ZLAB) EBITDA Margin (2020 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 7 years of EBITDA Margin data on file, last reported at 1711.1% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 165780.0% year-over-year to 1711.1%; the trailing twelve-month figure through Mar 2026 stood at 74.86% (up 15913.0% YoY), and the FY2025 full-year result was 7714.66%, down 764395.0% from the prior year.
- EBITDA Margin eased to 1711.1% in Q1 2026, from 21.06% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 21.06% in Q4 2025 to a low of 19111.56% in Q2 2024.
- A 5-year average of 2198.37% and a median of 138.77% in 2023 frame the typical range for EBITDA Margin.
- Peak annual rise in EBITDA Margin reached 1301211 bps in 2025, while the deepest fall reached 690822 bps in 2025.
- Tracing ZLAB's EBITDA Margin over 5 years: stood at 156.83% in 2022, then soared by 70 bps to 46.48% in 2023, then plunged by 33 bps to 61.78% in 2024, then soared by 134 bps to 21.06% in 2025, then tumbled by 8225 bps to 1711.1% in 2026.
- Business Quant data shows ZLAB's EBITDA Margin at 1711.1% in Q1 2026, 21.06% in Q4 2025, and 6974.57% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 30.35% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | -1,711.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,711.10% |
| Dec 31, 2025 | 21.06% |
| Sep 30, 2025 | -6,974.57% |
| Jun 30, 2025 | -6,099.44% |
| Mar 31, 2025 | -53.30% |
| Dec 31, 2024 | -61.78% |
| Sep 30, 2024 | -66.35% |
| Jun 30, 2024 | -19,111.56% |
| Mar 31, 2024 | -80.68% |
| Dec 31, 2023 | -46.48% |
| Sep 30, 2023 | -120.72% |
| Mar 31, 2023 | -110.71% |
| Dec 31, 2022 | -156.83% |
| Sep 30, 2022 | -223.47% |
| Jun 30, 2022 | -204.91% |
| Mar 31, 2022 | -173.04% |
| Dec 31, 2021 | -498.58% |
| Jun 30, 2021 | -461.81% |
| Mar 31, 2021 | -1,129.64% |
| Dec 31, 2020 | -631.09% |